Toxoplasmosis and the acquired immune deficiency syndrome.
The literature on toxoplasmosis in the acquired immune deficiency syndrome is reviewed with reference to more than 140 cases from various centres. The incidence, pathogenesis, clinical features, diagnosis, treatment and prognosis are considered.
Holliman
R E
RE
Public Health Laboratory Service, St George's Hospital, London, U.K.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000349:Africa; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D004338:Drug Combinations; D006801:Humans; D009894:Opportunistic Infections / Q000209:etiology*; D011379:Prognosis; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*
D000913:Antibodies, Protozoan; D004338:Drug Combinations; D013449:Sulfonamides; D011739:Pyrimethamine